MicroRNA regulation of cholesterol metabolism

Cholesterol

Volumn 2012, Issue , 2012, Pages

  Rotllan, Noemi ^a   Fernández Hernando, Carlos ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' O METHOXYETHYLOLIGORIBONUCLEOTIDE; 2' O METHYLOLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIVER X RECEPTOR; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 106B; MICRORNA 122; MICRORNA 122 ANTAGOMIR; MICRORNA 122 ANTISENSE OLIGONUCLEOTIDE; MICRORNA 33A; MICRORNA 33B; MICRORNA 758; MORPHOLINO OLIGONUCLEOTIDE; STEROL REGULATORY ELEMENT BINDING PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ABCG1 GENE; ALZHEIMER DISEASE; BIOGENESIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DRUG ACTIVITY; DYSLIPIDEMIA; GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC MANIPULATION; GENETIC TRANSFECTION; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; IRON DEFICIENCY; LIVER METABOLISM; MICRORNA REGULATION; NONHUMAN; NPC1 GENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RNA BINDING; RNA PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; TRANSLATION REGULATION;

EID: 84866166118     PISSN: 20901283     EISSN: 20901291     Source Type: Journal    
DOI: 10.1155/2012/847849     Document Type: Review

References (76)

1. Ikonen E., Mechanisms for cellular cholesterol transport: defects and human disease. Physiological Reviews 2006 86 4 1237 1261 2-s2.0-33749464296 10.1152/physrev.00022.2005 (Pubitemid 44521652)
2. Maxfield F. R., Tabas I., Role of cholesterol and lipid organization in disease. Nature 2005 438 7068 612 621 2-s2.0-28444479505 10.1038/nature04399 (Pubitemid 41740565)
3. Foley P., Lipids in Alzheimer's disease: a century-old story. Biochimica et Biophysica Acta 2010 1801 8 750 753 2-s2.0-77953235753 10.1016/j.bbalip.2010. 05.004
4. Tontonoz P., Kim J. B., Graves R. A., Spiegelman B. M., ADD1: a novel helix-loop-helix transcription factor associated with adipocyte determination and differentiation. Molecular and Cellular Biology 1993 13 8 4753 4759 2-s2.0-0027648820
5. Brown M. S., Goldstein J. L., The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997 89 3 331 340 2-s2.0-0030941803 10.1016/S0092-8674(00)80213-5 (Pubitemid 27220877)
6. Peet D. J., Janowski B. A., Mangelsdorf D. J., The LXRs: a new class of oxysterol receptors. Current Opinion in Genetics and Development 1998 8 5 571 575 2-s2.0-0032191340 10.1016/S0959-437X(98)80013-0 (Pubitemid 28477361)
7. Janowski B. A., Willy P. J., Devi T. R., Falck J. R., Mangelsdorf D. J., An oxysterol signalling pathway mediated by the nuclear receptor LXR α Nature 1996 383 6602 728 731 2-s2.0-0029805887 10.1038/383728a0 (Pubitemid 26360651)
8. Ambros V., MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003 113 6 673 676 2-s2.0-0038343499 10.1016/S0092-8674(03)00428-8 (Pubitemid 36724931)
9. Ambros V., The functions of animal microRNAs. Nature 2004 431 7006 350 355 2-s2.0-4644309196 10.1038/nature02871 (Pubitemid 39265675)
10. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
11. Elmén J., Lindow M., Schütz S., Lawrence M., Petri A., Obad S., Lindholm M., Hedtjärn M., Hansen H. F., Berger U., Gullans S., Kearney P., Sarnow P., Straarup E. M., Kauppinen S., LNA-mediated microRNA silencing in non-human primates. Nature 2008 452 7189 896 899 2-s2.0-42249093319 10.1038/nature06783 (Pubitemid 351550859)
12. Rayner K. J., Suárez Y., Dávalos A., Parathath S., Fitzgerald M. L., Tamehiro N., Fisher E. A., Moore K. J., Fernández- Hernando C., MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010 328 5985 1570 1573 2-s2.0-77953787211 10.1126/science.1189862
13. Ramirez C. M., Davalos A., Goedeke L., Salerno A. G., Warrier N., Cirera-Salinas D., Suarez Y., Fernandez-Hernando C., MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 2707 2714
14. Kim J., Yoon H., Ramirez C. M., Lee S. M., Hoe H. S., Fernandez-Hernando C., Kim J., miR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression. Experimental Neurology 2011 235 2 476 483
15. Iliopoulos D., Drosatos K., Hiyama Y., Goldberg I. J., Zannis V. I., MicroRNA-370 controls the expression of MicroRNA-122 and Cpt1 α and affects lipid metabolism. Journal of Lipid Research 2010 51 6 1513 1523 2-s2.0-77952707662 10.1194/jlr.M004812
16. Gerin I., Bommer G. T., McCoin C. S., Sousa K. M., Krishnan V., MacDougald O. A., Roles for miRNA-378/378 in adipocyte gene expression and lipogenesis. American Journal of Physiology 2010 299 2 E198 E206 2-s2.0-77954932826 10.1152/ajpendo.00179.2010
17. Lin Q., Gao Z., Alarcon R. M., Ye J., Yun Z., A role of miR-27 in the regulation of adipogenesis. FEBS Journal 2009 276 8 2348 2358 2-s2.0-63049108381 10.1111/j.1742-4658.2009.06967.x
18. Nakanishi N., Nakagawa Y., Tokushige N., Aoki N., Matsuzaka T., Ishii K., Yahagi N., Kobayashi K., Yatoh S., Takahashi A., Suzuki H., Urayama O., Yamada N., Shimano H., The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochemical and Biophysical Research Communications 2009 385 4 492 496 2-s2.0-67349179168 10.1016/j.bbrc.2009.05.058
19. Chen T., Li Z., Tu J., Zhu W., Ge J., Zheng X., Yang L., Pan X., Yan H., Zhu J., MicroRNA-29a regulates pro-inflammatory cytokine secretion and scavenger receptor expression by targeting LPL in oxLDL-stimulated dendritic cells. FEBS Letters 2011 585 4 657 663 2-s2.0-79951579619 10.1016/j.febslet.2011.01.027
20. Esau C., Kang X., Peralta E., Hanson E., Marcusson E. G., Ravichandran L. V., Sun Y., Koo S., Perera R. J., Jain R., Dean N. M., Freier S. M., Bennett C. F., Lollo B., Griffey R., MicroRNA-143 regulates adipocyte differentiation. The Journal of Biological Chemistry 2004 279 50 52361 52365 2-s2.0-10344243662 10.1074/jbc.C400438200 (Pubitemid 39656612)
21. Hoekstra M., van der Sluis R. J., Kuiper J., Van Berkel T. J. C., Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. Journal of Nutritional Biochemistry 2012 23 6 622 628 2-s2.0-84860887952 10.1016/j.jnutbio.2011.03.005
22. Krützfeldt J., Rajewsky N., Braich R., Rajeev K. G., Tuschl T., Manoharan M., Stoffel M., Silencing of microRNAs in vivo with 'antagomirs' Nature 2005 438 7068 685 689 2-s2.0-28444469246 10.1038/nature04303 (Pubitemid 41740580)
23. Esau C., Davis S., Murray S. F., Yu X. X., Pandey S. K., Pear M., Watts L., Booten S. L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B. A., Freier S., Bennett C. F., Bhanot S., Monia B. P., miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 2006 3 2 87 98 2-s2.0-33645075443 10.1016/j.cmet.2006.01.005
24. Marquart T. J., Allen R. M., Ory D. S., Baldan A., miR-33 links SREBP-2 induction to repression of sterol transporters. Proceedings of the National Academy of Sciences of the United States of America 2010 107 27 12228 12232 2-s2.0-77955456415 10.1073/pnas.1005191107
25. Najafi S. H., Kristo F., Li Y., Shioda T., Cohen D. E., Gerszten R. E., Näär A. M., MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 2010 328 5985 1566 1569 2-s2.0-77953780835 10.1126/science.1189123
26. Fernández C., Lobo M. D. V. T., Gómez-Coronado D., Lasunción M. A., Cholesterol is essential for mitosis progression and its deficiency induces polyploid cell formation. Experimental Cell Research 2004 300 1 109 120 2-s2.0-4644372454 10.1016/j.yexcr.2004.06.029 (Pubitemid 39286221)
27. Fernández C., Martín M., Gómez-Coronado D., Lasunción M. A., Effects of distal cholesterol biosynthesis inhibitors on cell proliferation and cell cycle progression. Journal of Lipid Research 2005 46 5 920 929 2-s2.0-27244433832 10.1194/jlr.M400407-JLR200
28. Glass C. K., Witztum J. L., Atherosclerosis: The road ahead. Cell 2001 104 4 503 516 2-s2.0-0035936802 10.1016/S0092-8674(01)00238-0 (Pubitemid 32201946)
29. Zelcer N., Tontonoz P., Liver X receptors as integrators of metabolic and inflammatory signaling. Journal of Clinical Investigation 2006 116 3 607 614 2-s2.0-33644651160 10.1172/JCI27883 (Pubitemid 43326865)
30. Zelcer N., Hong C., Boyadjian R., Tontonoz P., LXR regulates cholesterol uptake through idol-dependent ubiquitination of the LDL receptor. Science 2009 325 5936 100 104 2-s2.0-67650092919 10.1126/science.1168974
31. Tall A. R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N., HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metabolism 2008 7 5 365 375 2-s2.0-42649134146 10.1016/j.cmet.2008.03.001 (Pubitemid 351598023)
32. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
33. Friedman R. C., Farh K. K. H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
34. Griffiths-Jones S., Saini H. K., Van Dongen S., Enright A. J., miRBase: tools for microRNA genomics. Nucleic Acids Research 2008 36 1 D154 D158 2-s2.0-38549150275 10.1093/nar/gkm952 (Pubitemid 351149713)
35. Catalucci D., Gallo P., Condorelli G., Advances in molecular genetics, genomics, proteomics, metabolomics, and systems biology: microRNAs in cardiovascular biology and heart disease. Circulation 2009 2 4 402 408 2-s2.0-77449122322 10.1161/CIRCGENETICS.109.857425
36. Chang T. C., Mendell J. T., MicroRNAs in vertebrate physiology and human disease. Annual Review of Genomics and Human Genetics 2007 8 215 239 2-s2.0-35348821616 10.1146/annurev.genom.8.080706.092351
37. Van Rooij E., Marshall W. S., Olson E. N., Toward microRNA-based therapeutics for heart disease: the sense in antisense. Circulation Research 2008 103 9 919 928 2-s2.0-55449100829 10.1161/CIRCRESAHA.108.183426
38. Alevizos I., Illei G. G., MicroRNAs as biomarkers in rheumatic diseases. Nature Reviews Rheumatology 2010 6 7 391 398 2-s2.0-77954315865 10.1038/nrrheum.2010.81
39. Cheung O., Puri P., Eicken C., Contos M. J., Mirshahi F., Maher J. W., Kellum J. M., Min H., Luketic V. A., Sanyal A. J., Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 2008 48 6 1810 1820 2-s2.0-58149386462 10.1002/hep.22569
40. Fichtlscherer S., Zeiher A. M., Dimmeler S., Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 2383 2390
41. Friel A. M., Corcoran C., Crown J., O'Driscoll L., Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer. Breast cancer research and treatment 2010 123 3 613 625 2-s2.0-78951475136
42. Kosaka N., Iguchi H., Ochiya T., Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Science 2010 101 10 2087 2092 2-s2.0-77957091969 10.1111/j.1349-7006.2010.01650.x
43. Rabinowits G., Gerel-Taylor C., Day J. M., Taylor D. D., Kloecker G. H., Exosomal microRNA: a diagnostic marker for lung cancer. Clinical Lung Cancer 2009 10 1 42 46 2-s2.0-62549125455 10.3816/CLC.2009.n.006
44. Rosell R., Wei J., Taron M., Circulating microRNA signatures of tumor-derived exosomes for early diagnosis of non-small-cell lung cancer. Clinical Lung Cancer 2009 10 1 8 9 2-s2.0-62549116582 10.3816/CLC.2009.n.001
45. Taylor D. D., Gercel-Taylor C., MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic Oncology 2008 110 1 13 21 2-s2.0-45449093192 10.1016/j.ygyno.2008.04.033 (Pubitemid 351853251)
46. Forman J. J., Coller H. A., The code within the code: microRNAs target coding regions. Cell Cycle 2010 9 8 1533 1541 2-s2.0-77953563697
47. Lytle J. R., Yario T. A., Steitz J. A., Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proceedings of the National Academy of Sciences of the United States of America 2007 104 23 9667 9672 2-s2.0-34547441263 10.1073/pnas.0703820104 (Pubitemid 47175324)
48. Orom U. A., Nielsen F. C., Lund A. H., MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and enhances their translation. Molecular Cell 2008 30 4 460 471 2-s2.0-43449090367 10.1016/j.molcel.2008.05.001 (Pubitemid 351672378)
49. Rigoutsos I., New tricks for animal micrornas: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Research 2009 69 8 3245 3248 2-s2.0-65949121645 10.1158/0008-5472.CAN-09-0352
50. Henke J. I., Goergen D., Zheng J., Song Y., Schüttler C. G., Fehr C., Jünemann C., Niepmann M., MicroRNA-122 stimulates translation of hepatitis C virus RNA. The EMBO Journal 2008 27 24 3300 3310 2-s2.0-58049217312 10.1038/emboj.2008.244
51. Vasudevan S., Tong Y., Steitz J. A., Switching from repression to activation: microRNAs can up-regulate translation. Science 2007 318 5858 1931 1934 2-s2.0-36749026906 10.1126/science.1149460
52. Vasudevan S., Tong Y., Steitz J. A., Cell cycle control of microRNA-mediated translation regulation. Cell Cycle 2008 7 11 1545 1549 2-s2.0-45849091123 (Pubitemid 351881318)
53. Liu J., Control of protein synthesis and mRNA degradation by microRNAs. Current Opinion in Cell Biology 2008 20 2 214 221 2-s2.0-41549110185 10.1016/j.ceb.2008.01.006
54. Pillai R. S., Bhattacharyya S. N., Filipowicz W., Repression of protein synthesis by miRNAs: how many mechanisms? Trends in Cell Biology 2007 17 3 118 126 2-s2.0-33846277696 10.1016/j.tcb.2006.12.007 (Pubitemid 46357525)
55. Havens M. A., Reich A. A., Duelli D. M., Hastings M. L., Biogenesis of mammalian microRNAs by a non-canonical processing pathway2012. Nucleic Acids Research 40 10 4626 4640
56. Hutvágner G., Simard M. J., Mello C. C., Zamore P. D., Sequence-specific inhibition of small RNA function. PLoS Biology 2004 2 4 E98 2-s2.0-19344378192 10.1371/journal.pbio.0020098 (Pubitemid 39234504)
57. Orom U. A., Kauppinen S., Lund A. H., LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006 372 1-2 137 141 2-s2.0-33646027887 10.1016/j.gene.2005.12.031
58. Flynt A. S., Li N., Thatcher E. J., Solnica-Krezel L., Patton J. G., Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate. Nature Genetics 2007 39 2 259 263 2-s2.0-33846609167 10.1038/ng1953 (Pubitemid 46184359)
59. Boutla A., Delidakis C., Tabler M., Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes. Nucleic Acids Research 2003 31 17 4973 4980 2-s2.0-0345064195 10.1093/nar/gkg707 (Pubitemid 37441863)
60. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T., Identification of tissue-specific MicroRNAs from mouse. Current Biology 2002 12 9 735 739 2-s2.0-0037197803 10.1016/S0960-9822(02)00809-6 (Pubitemid 34455427)
61. Girard M., Jacquemin E., Munnich A., Lyonnet S., Henrion-Caude A., miR-122, a paradigm for the role of microRNAs in the liver. Journal of Hepatology 2008 48 4 648 656 2-s2.0-39849108178 10.1016/j.jhep.2008.01.019
62. Elmén J., Lindow M., Silahtaroglu A., Bak M., Christensen M., Lind-Thomsen A., Hedtjärn M., Hansen J. B., Hansen H. F., Straarup E. M., McCullagh K., Kearney P., Kauppinen S., Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Research 2008 36 4 1153 1162 2-s2.0-40249106014 10.1093/nar/gkm1113 (Pubitemid 351330933)
63. Castoldi M., Spasic M. V., Altamura S., Elmén J., Lindow M., Kiss J., Stolte J., Sparla R., D'Alessandro L. A., Klingmüller U., Fleming R. E., Longerich T., Gröne H. J., Benes V., Kauppinen S., Hentze M. W., Muckenthaler M. U., The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. Journal of Clinical Investigation 2011 121 4 1386 1396 2-s2.0-79953316619 10.1172/JCI44883
64. Jopling C. L., Yi M., Lancaster A. M., Lemon S. M., Sarnow P., Molecular biology: modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005 309 5740 1577 1581 2-s2.0-24644483623 10.1126/science.1113329 (Pubitemid 41266486)
65. Jopling C. L., Schütz S., Sarnow P., Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host and Microbe 2008 4 1 77 85 2-s2.0-46749124698 10.1016/j.chom.2008.05.013 (Pubitemid 351944051)
66. Randall G., Panis M., Cooper J. D., Tellinghuisen T. L., Sukhodolets K. E., Pfeffer S., Landthaler M., Landgraf P., Kan S., Lindenbach B. D., Chien M., Weir D. B., Russo J. J., Ju J., Brownstein M. J., Sheridan R., Sander C., Zavolan M., Tuschl T., Rice C. M., Cellular cofactors affecting hepatitis C virus infection and replication. Proceedings of the National Academy of Sciences of the United States of America 2007 104 31 12884 12889 2-s2.0-34547913440 10.1073/pnas.0704894104 (Pubitemid 47255249)
67. Shan Y., Zheng J., Lambrecht R. W., Bonkovsky H. L., Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 2007 133 4 1166 1174 2-s2.0-34848878881 10.1053/j.gastro.2007.08.002 (Pubitemid 47494462)
68. Gerin I., Clerbaux L. A., Haumont O., Lanthier N., Das A. K., Burant C. F., Leclercq I. A., MacDougald O. A., Bommer G. T., Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. The Journal of Biological Chemistry 2010 285 44 33652 33661 2-s2.0-77958553499 10.1074/jbc.M110.152090
69. Marquart T. J., Allen R. M., Ory D. S., Baldan A., miR-33 links SREBP-2 induction to repression of sterol transporters. Proceedings of the National Academy of Sciences of the United States of America 2010 107 27 12228 12232 2-s2.0-77955456415 10.1073/pnas.1005191107
70. Plösch T., Kosters A., Groen A. K., Kuipers F., The ABC of hepatic and intestinal cholesterol transport. Handbook of experimental pharmacology 2005 170 465 482 2-s2.0-33645777493
71. Rayner K. J., Esau C. C., Hussain F. N., McDaniel A. L., Marshall S. M., van Gils J. M., Ray T. D., Sheedy F. J., Goedeke L., Liu X., Khatsenko O. G., Kaimal V., Lees C. J., Fernandez-Hernando C., Fisher E. A., Temel R. E., Moore K. J., Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature 2011 478 404 407
72. Dávalos A., Goedeke L., Smibert P., Ramírez C. M., Warrier N. P., Andreo U., Cirera-Salinas D., Rayner K., Suresh U., Pastor-Pareja J. C., Esplugues E., Fisher E. A., Penalva L. O. F., Moore K. J., Suárez Y., Lai E. C., Fernández-Hernando C., miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proceedings of the National Academy of Sciences of the United States of America 2011 108 22 9232 9237 2-s2.0-79959326172 10.1073/pnas.1102281108
73. Cirera-Salinas D., Pauta M., Allen R. M., Salerno A. G., Ramirez C. M., Chamorro-Jorganes A., Wanschel A. C., Lasuncion M. A., Morales-Ruiz M., Suarez Y., Baldan A., Esplugues E., Fernandez-Hernando C., Mir-33 regulates cell proliferation and cell cycle progression. Cell Cycle 2012 11 5
74. Wahrle S. E., Jiang H., Parsadanian M., Kim J., Li A., Knoten A., Jain S., Hirsch-Reinshagen V., Wellington C. L., Bales K. R., Paul S. M., Holtzman D. M., Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. Journal of Clinical Investigation 2008 118 2 671 682 2-s2.0-38849086036 10.1172/JCI33622 (Pubitemid 351206556)
75. Hirsch-Reinshagen V., Zhou S., Burgess B. L., Bernier L., McIsaac S. A., Chan J. Y., Tansley G. H., Cohn J. S., Hayden M. R., Wellington C. L., Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. The Journal of Biological Chemistry 2004 279 39 41197 41207 2-s2.0-4644295495 10.1074/jbc.M407962200 (Pubitemid 39287722)
76. Koldamova R., Staufenbiel M., Lefterov I., Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. The Journal of Biological Chemistry 2005 280 52 43224 43235 2-s2.0-30044438463 10.1074/jbc.M504513200 (Pubitemid 43049289)